Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Multiple bone and joint disease in a sickle cell anaemia patient: a case report

    John Ayodele Olaniyi, Adekunle E Alagbe, Olutoogun O Toluwalase, Olorunsogo E Busari
    e2012023
    2012-05-03
    https://doi.org/10.4084/mjhid.2012.023
    1410
    PDF: 821
    HTML: 1777
  • Mild clinical course of COVID-19 infection in chronic myeloid leukemia (CML) patients receiving tyrosine kinase inhibitors (TKIs) without interruption

    Judit Demeter, Julia Weisinger, Zsolt Nagy
    e2021022
    2021-02-26
    https://doi.org/10.4084/mjhid.2021.022
    1609
    PDF: 590
    HTML: 279
  • Improvement of liver involvement in familial Mediterranean fever after introduction of canakinumab: a case report Liver involvement in familial Mediterranean fever

    Maria Grazia Massaro, Maurizio Pompili, Ludovico Luca Sicignano, Fabrizio Pizzolante, Elena Verrecchia, Fabio Maria Vecchio, Donato Rigante, Raffaele Manna
    e20200059
    2020-08-29
    https://doi.org/10.4084/mjhid.2020.059
    1536
    PDF: 989
    HTML: 436
  • Ponatinib induced improvement of cutaneous lesions associated to accelerated phase of Ph-positive chronic myeloid leukemia

    Massimo Breccia, Gioia Colafigli, Luisa Quattrocchi, elisabetta abruzzese, giuliana alimena
    e2016016
    2016-02-20
    https://doi.org/10.4084/mjhid.2016.016
    3043
    PDF: 763
    HTML: 1975
    figure 1: 234
    figure 2: 225
  • LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE

    Massimo Breccia, Corrado Girmenia, Roberto Latagliata, Giuseppina Loglisci, Michelina Santopietro, Vincenzo Federico, Luigi Petrucci, Alessandra Serrao, Adriano Salaroli, Giuliana Alimena
    e2011021
    2011-05-16
    https://doi.org/10.4084/mjhid.2011.021
    1850
    PDF: 875
    HTML: 935
    jdoe, table 2 infections CML .doc: 256
    jdoe, table 1 infections CML .doc: 233
  • MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASE IN EGYPTIAN CHILDREN

    Nermeen Galal, Jeannette Boutros, Aisha Marsafy, Xiao-Fei Kong, Jacqueline Feinberg, Jean-Laurent Casanova, Stéphanie Boisson-Dupuis, Jacinta Bustamante
    e2012033
    2012-05-07
    https://doi.org/10.4084/mjhid.2012.033
    3656
    PDF: 946
    HTML: 1174
    Cover: 237
  • COVID-19 induces prolonged immunological exhaustion leading to relapse of hematological malignancies except in hematopoietic cell transplant recipients

    SUPARNO CHAKRABARTI, Snigdha Banerjee, Mahak Agarwal, Gitali Bhagawati, Nilanjan Saha, SARITA JAISWAL
    e2025042
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.042
    1203
    PDF: 844
    HTML: 214
  • Genomic integration of HHV-6 mimicking viral reactivation after autologous stem cell transplantation

    rossana mineri, Jacopo Mariotti, Barbara Sarina, Lucio Morabito, roberto crocchiolo, stefania bramanti, tiziana sarno, federica tordato, carmelo carlo-stella, armando santoro, Luca Castagna
    e2018013
    2018-02-15
    https://doi.org/10.4084/mjhid.2018.013
    3252
    PDF: 803
    HTML: 452
  • OUTCOMES OF OVERT AND NON-OVERT DISSEMINATED INTRAVASCULAR COAGULATION USING THE ISTH DIC SCORING SYSTEM IN CHILDREN: A SINGLE-CENTER STUDY

    Jassada Buaboonnam, Chonthida Wnagkittikal, Nattee Narkbunnam, Nassawee Vathana, Chayamon Takpradit, Kamon Phuakpet, Phakatip Sinlapamongkolkul, Kleebsabai Sanpakit, Khemajira Karaketklang, Bunchoo Pongtanakul
    e2023004
    2023-01-01
    https://doi.org/10.4084/MJHID.2023.004
    1559
    PDF: 1334
    HTML: 882
  • ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES

    Daniel Olson, Abraham Tareq Yacoub, Gelenis Domingo, John Norman Greene
    e2014068
    2014-08-28
    https://doi.org/10.4084/mjhid.2014.068
    2511
    PDF: 817
    HTML: 2160
    Untitled: 293
    Untitled: 201
    Untitled: 235
    Untitled: 215
    Untitled: 233
    Untitled: 248
    Untitled: 239
  • Sinopharm Vaccine, SARS-CoV-2 breakthrough infections and Hemoglobinopathies

    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    e2022060
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.060
    895
    PDF: 538
    HTML: 236
  • PRE AND POST-MONOCLONAL INFUSION NEUTRALIZING ACTIVITY IN A SUBGROUP OF PATIENTS TREATED IN THE PRESENCE OF TWO SARS-COV-2 DOMINANT VARIANT OF CONCERN (VOCS) AND AN ONGOING VACCINATION. OVERALL CLINICAL EFFICACY OF TWO MONOCLONAL ANTIBODIES ASSOCIATION IN UMBRIA

    Elisabetta Schiaroli, Giuseppe Vittorio De Socio, Anna Gidari, Lisa Malincarne, Sara Benedetti , Alessandra Lanzi, Sabrina Bastianelli, Sara Pierucci, Chiara busti, Daniela Francisci
    e2022050
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.050
    1968
    PDF: 637
    HTML: 283
  • A case of multiple myeloma in a patient in treatment for chronic lymphocytic leukemia

    Mario Biglietto, Ugo Coppetelli, Luciano Fiori, Martina Gherardini, Raffaele Maglione, Alessandro Pulsoni, Azzurra Anna Romeo
    e2025033
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.033
    999
    PDF: 768
    HTML: 218
  • HEMATOLOGICAL CHARACTERISTICS OF YEMENI ADULTS AND CHILDREN WITH VISCERAL LEISHMANIASIS. COULD EOSINOPENIA BE A SUSPICION INDEX?

    Jameel Al-Ghazaly, Waled Al-Dubai, Munasser Abdullah, Leila Al-Gharasi
    e2017056
    2017-09-01
    https://doi.org/10.4084/mjhid.2017.056
    3616
    PDF: 1339
    HTML: 1502
  • APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS

    Rita Wilson Dib, Ray Hachem, Anne-Marie P Chaftari, Issam I Raad
    e2018028
    2018-05-01
    https://doi.org/10.4084/mjhid.2018.028
    3026
    PDF: 1191
    HTML: 522
    Preferred Reviewers: 256
251 - 265 of 265 items << < 1 2 3 4 5 6 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.